Skip to main content
Tags: hydroxychloroquine | trial

France Turns on Hydroxychloroquine

a 200 mg bottle of hydroxychloroquine tablets are shown
(George Frey/AFP via Getty Images)

By    |   Tuesday, 26 May 2020 11:59 AM EDT

France’s public health agency has issued an advisory warning against the use of hydroxychloroquine outside of clinical trials just after the country’s medicines regulator suspended clinical trials that use the drug, Politico reports.

The French High Council for Public Health now recommends that the drug not be prescribed outside of clinical trials, but French drugs regulator ANSM also announced on Tuesday that new patients should not be enrolled in clinical trials involving hydroxychloroquine, which is usually used as a treatment for lupus and to prevent malaria.

The decision to crack down on the use of hydroxychloroquine comes just days after the Lancet, one of the world’s leading medical journals, published a report that cast doubt on its effectiveness at treating the coronavirus.

“Hydroxychloroquine or chloroquine, often in combination with a second-generation macrolide, are being widely used for treatment of COVID-19, despite no conclusive evidence of their benefit,” reads the study, which was published in the Lancet last Friday. “Although generally safe when used for approved indications such as autoimmune disease or malaria, the safety and benefit of these treatment regimens are poorly evaluated in COVID-19.”

The researchers utilized data compiled from hundreds of hospitals on six continents, with patients hospitalized from late December through mid-April who all tested positive for SARS-CoV-2.

They found that Hydroxychloroquine “was associated with no evidence of benefit, but instead was associated with an increase in the risk of ventricular arrhythmias and a greater hazard for in-hospital death with COVID-19. These findings suggest that these drug regimens should not be used outside of clinical trials and urgent confirmation from randomized clinical trials is needed.”

Theodore Bunker

Theodore Bunker, a Newsmax writer, has more than a decade covering news, media, and politics.

© 2024 Newsmax. All rights reserved.


US
France’s public health agency has issued an advisory warning against the use of hydroxychloroquine outside of clinical trials just after the country’s medicines regulator suspended clinical trials that use the drug, Politico reports.
hydroxychloroquine, trial
269
2020-59-26
Tuesday, 26 May 2020 11:59 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
Get the NewsmaxTV App for iOS Get the NewsmaxTV App for Android Scan QR code to get the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved